BackSilexion Therapeutics Overview
Silexion Therapeutics Corp

Silexion Therapeutics Return on Equity

Valuation check: SLXN's ROE is 11668.18%, above the sector sector average of 11.67%.

Get informed when a big investor buys or sells

+ Follow

ROE

11668.18%

Return on Equity

11668.18%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Silexion Therapeutics (SLXN) FAQ

As of the most recent data, SLXN shows a ROE of 11668.18%. That is above the sector sector average of 11.67%. Scroll down for historical charts and peer comparison views.

The its sector sector average ROE is about 11.67%. Silexion Therapeutics is at 11668.18%, which is higher that average. That is roughly 99920.7% above the sector mean. Use the comparison chart on this page to see how SLXN stacks up against individual peers as well.

Check the historical chart to see whether SLXN's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Silexion Therapeutics with peers to see if the move is company-specific or sector-wide.

Besides this return on equity page, Stockcircle has Silexion Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 11668.18%) with ownership activity and broader fundamentals.